Amkor Technology Investing Cash Flow decreased by 1.3% to -$334.72M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 430.8%, from -$63.05M to -$334.72M. Over 4 years (FY 2021 to FY 2025), Investing Cash Flow shows relatively stable performance with a -1.6% CAGR.
A negative value typically signals investment in future growth, while a positive value may indicate divestment or the maturity of a large investment portfolio.
This metric is the net total of all cash inflows and outflows related to investing activities, including capital expendi...
Most mature healthcare companies maintain a negative net investing cash flow due to ongoing R&D and infrastructure investment.
net_cash_from_investing| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$157.12M | -$314.87M | -$307.51M | -$240.01M | -$286.66M | -$196.54M | -$283.95M | -$155.70M | -$263.17M | -$278.03M | -$255.01M | -$86.10M | -$188.96M | -$226.69M | -$298.57M | -$63.05M | -$142.74M | -$348.72M | -$330.53M | -$334.72M |
| QoQ Change | — | -100.4% | +2.3% | +22.0% | -19.4% | +31.4% | -44.5% | +45.2% | -69.0% | -5.6% | +8.3% | +66.2% | -119.5% | -20.0% | -31.7% | +78.9% | -126.4% | -144.3% | +5.2% | -1.3% |
| YoY Change | — | — | — | — | -82.4% | +37.6% | +7.7% | +35.1% | +8.2% | -41.5% | +10.2% | +44.7% | +28.2% | +18.5% | -17.1% | +26.8% | +24.5% | -53.8% | -10.7% | -430.8% |